VIVITROL 380mg

ApprovedCompleted

0 views this week 0 watching⚡ Active

Interest: 40/100

Hype Score

Development Stage

✓

Pre-clinical

✓

Phase 1

✓

Phase 2

✓

Phase 3

Approved

Indication / Disease

Opioid Dependence

Conditions

Opioid Dependence

Trial Timeline

Jan 1, 2011 → May 1, 2014

NCT ID

NCT01453374

About VIVITROL 380mg

VIVITROL 380mg is a approved stage product being developed by Alkermes for Opioid Dependence. The current trial status is completed. This product is registered under clinical trial identifier NCT01453374. Target conditions include Opioid Dependence.

What happened to similar drugs?

7 of 20 similar drugs in Opioid Dependence were approved

Approved (7) Terminated (7) Active (7)

✅Naldemedine + PlaceboShionogiApproved

✅Polyethylene Glycol 3350 + MovantikAstraZenecaApproved

✅Naltrexone for extended-release injectable suspension + Oral naltrexoneAlkermesApproved

✅NaltrexoneAlkermesApproved

✅methylnaltrexone + placeboBausch HealthApproved

✅Methylnaltrexone bromideBausch HealthApproved

✅Methylnaltrexone + PlaceboBausch HealthApproved

Hype Score Breakdown

Clinical

Activity

Company

Novelty

Community

Clinical Trials (1)

NCT ID	Phase	Status	Start	Completion	Indication
NCT01453374	Approved	Completed	Jan 1, 2011	May 1, 2014	Opioid Dependence

Competing Products

20 competing products in Opioid Dependence

See all competitors

Product	Company	Stage	Hype Score
SUBLOCADE	Indivior PLC	Phase 3	29
SUBLOCADE	Indivior PLC	Phase 3	29
ASP8082 + morphine + Placebo	Astellas Pharma	Phase 1	29
ASP8062 + Placebo ASP8062 + buprenorphine/naloxone	Astellas Pharma	Phase 1	29
ASP8062 + Placebo ASP8062 + buprenorphine/naloxone	Astellas Pharma	Phase 2	27
Naldemedine + Placebo	Shionogi	Phase 3	40
Naldemedine + Placebo	Shionogi	Approved	50
Naldemedine	Shionogi	Phase 1/2	39
Naldemedine + Placebo	Shionogi	Phase 3	40
Placebo + Naldemedine	Shionogi	Phase 2	35
Naldemedine + Placebo	Shionogi	Phase 3	40
Naldemedine + Placebo	Shionogi	Phase 2	35
Naloxegol	Kyowa Kirin	Pre-clinical	26
naloxegol + non-PAMORA laxative	Kyowa Kirin	Pre-clinical	18
Naloxegol	Kyowa Kirin	Pre-clinical	26
Naloxegol	Kyowa Kirin	Pre-clinical	26
Brenipatide + Placebo + Buprenorphine	Eli Lilly	Phase 2	42
NKTR-118 + NKTR-118 + Placebo	AstraZeneca	Phase 3	32
Naloxegol + Naloxegol	AstraZeneca	Phase 1	29
NKTR-118 + Usual care	AstraZeneca	Phase 3	40